Onkar P. Kulkarni
- Nephrology top 0.5%
- Renal Diseases and Glomerulopathies 7
- Immunology top 2%
- Immune Response and Inflammation 16
- T-cell and B-cell Immunology 7
- Immune cells in cancer 7
- interferon and immune responses 6
- Rheumatology top 1%
- Systemic Lupus Erythematosus Research 19
- Molecular Biology top 5%
- Clinical Biochemistry top 5%
-
- Chemokine receptors and signaling 9
-
- Synthesis and biological activity 7
- Co-authors
- Hans‐Joachim AndersShrikant R. MulayStephan SegererMurthy N. DarisipudiJulia LichtnekertMaciej LechRamanjaneyulu AllamDirk Eulberg
- Cited by
- NephrologyImmunologyRheumatology
- Journals
- Journal of Clinical Investigation (1 paper)The Journal of Experimental Medicine (2 papers)The Journal of Immunology (1 paper)
- Partner nations
- IndiaGermanyUnited States
In The Last Decade
Onkar P. Kulkarni
99 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Nephrology 863
- Immunology 1.5k
- Rheumatology 613
- Molecular Biology 1.5k
- Clinical Biochemistry 125
Countries citing papers authored by Onkar P. Kulkarni
This map shows the geographic impact of Onkar P. Kulkarni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Onkar P. Kulkarni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Onkar P. Kulkarni more than expected).
Fields of papers citing papers by Onkar P. Kulkarni
This network shows the impact of papers produced by Onkar P. Kulkarni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Onkar P. Kulkarni. The network helps show where Onkar P. Kulkarni may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Onkar P. Kulkarni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 4 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 9 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 22 | |
| 8 | 2023 | 10 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 23 | |
| 11 | 2023 | 1 | |
| 12 | 2022 | 19 | |
| 13 | 2016 | 65 | |
| 14 | 2014 | 4 | |
| 15 | 2014 | 76 | |
| 16 | 2013 | 72 | |
| 17 | 2011 | 94 | |
| 18 | 2009 | 60 | |
| 19 | 2009 | 67 | |
| 20 | 2008 | 92 |
About Onkar P. Kulkarni
Onkar P. Kulkarni is a scholar working on Immunology, Nephrology and Rheumatology, having authored 105 papers that have together received 3.8k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (19 papers), Immune Response and Inflammation (16 papers), Chemokine receptors and signaling (9 papers), Synthesis and biological activity (7 papers), T-cell and B-cell Immunology (7 papers), Renal Diseases and Glomerulopathies (7 papers), Immune cells in cancer (7 papers) and interferon and immune responses (6 papers). The work is most often cited by research in Nephrology (863 citations), Immunology (1.5k citations) and Rheumatology (613 citations). Onkar P. Kulkarni has collaborated with scholars based in India, Germany and United States. Frequent co-authors include Hans‐Joachim Anders, Shrikant R. Mulay, Stephan Segerer, Murthy N. Darisipudi, Julia Lichtnekert, Maciej Lech, Ramanjaneyulu Allam, Dirk Eulberg, Mi Heon Ryu and Rahul D. Pawar. Their work appears in journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.